Delivery Order SPE2DB22D2206-SPE2DB25FKC02
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 15, 2025, for the supply of Prevymis 480 mg tablets in quantities of 7 per unit. This firm fixed-price delivery order, valued at $4,719.34, represents a non-competitive award executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,438.70 by the Defense Logistics Agency on June 18, 2025, for the supply of Prevymis 480 mg tablets in quantities of 7 units. The contract is a firm fixed-price delivery order with an ultimate completion date of July 11, 2025, and was competitively awarded with no set-aside designation. Performance will be executed from the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,719.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Prevymis 480 mg tablets in packages of seven units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Prevymis 480 mg tablets (quantity: 7 units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,440 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of September 19, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,279.84 on September 15, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,307.41 by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, has an ultimate completion date of September 23, 2025. The award was made on a competitive basis with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $35,097.32 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside delivery order operates under firm fixed pricing and represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The work will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $46,118.20 by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKC02Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven units. The contract carries a ceiling value of $9,438.70 under firm fixed price terms, with an ultimate completion date of October 16, 2025. This delivery order represents a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. The award reflects AmerisourceBergen's established role as a critical federal pharmaceutical distributor specializing in a broad portfolio of medications and medical supplies for defense and veteran healthcare procurement. No set-aside designation was applied to this competitive award, consistent with the company's demonstrated capability to meet federal procurement requirements through open competition. The delivery order supports DLA's medical supply chain operations, which provide pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/24/25 |